Medtronic Plc Stock Working Capital

MDT Stock

USD 80.38 0.91 1.12%

Medtronic PLC fundamentals help investors to digest information that contributes to Medtronic PLC's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic PLC stock.

	Last Reported	Projected for Next Year
Net Working Capital	14.5 B	13.5 B
Change In Working Capital	-870.3 M	-826.8 M
Working Capital	0.00	0.00

Net Working Capital is likely to drop to about 13.5 B in 2024. Change In Working Capital is likely to gain to about (826.8 M) in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medtronic PLC Company Working Capital Analysis

Medtronic PLC's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Medtronic PLC Working Capital

12.62 B

Most of Medtronic PLC's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Medtronic Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Medtronic PLC is extremely important. It helps to project a fair market value of Medtronic Stock properly, considering its historical fundamentals such as Working Capital. Since Medtronic PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medtronic PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medtronic PLC's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Long Term Debt	Good Will	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital
Total Assets		0.99	0.97	0.78	0.9	0.99	0.88	0.15	0.91	0.87	0.98	0.98	0.37	-0.97	0.86	0.43	-0.71	-0.87	0.14	0.5	-0.69	-0.61	-0.54	-0.49	0.49
Total Stockholder Equity	0.99		0.94	0.74	0.9	0.96	0.86	0.08	0.87	0.91	0.95	0.99	0.3	-0.97	0.89	0.32	-0.78	-0.89	0.21	0.4	-0.77	-0.7	-0.62	-0.57	0.56
Net Debt	0.97	0.94		0.85	0.89	0.99	0.9	0.2	0.93	0.78	0.99	0.92	0.47	-0.91	0.78	0.6	-0.55	-0.8	0.06	0.65	-0.53	-0.45	-0.4	-0.39	0.37
Retained Earnings	0.78	0.74	0.85		0.78	0.82	0.8	-0.03	0.79	0.57	0.86	0.71	0.59	-0.69	0.61	0.62	-0.29	-0.7	-0.02	0.72	-0.2	-0.18	-0.2	-0.21	0.13
Net Receivables	0.9	0.9	0.89	0.78		0.89	0.92	0.03	0.74	0.81	0.89	0.86	0.48	-0.8	0.81	0.3	-0.58	-0.74	0.16	0.36	-0.56	-0.55	-0.54	-0.51	0.5
Total Liab	0.99	0.96	0.99	0.82	0.89		0.9	0.22	0.94	0.8	0.99	0.95	0.45	-0.94	0.79	0.55	-0.61	-0.82	0.05	0.62	-0.59	-0.49	-0.42	-0.38	0.4
Total Current Assets	0.88	0.86	0.9	0.8	0.92	0.9		0.17	0.78	0.7	0.89	0.81	0.72	-0.79	0.7	0.44	-0.5	-0.65	0.05	0.52	-0.46	-0.4	-0.36	-0.32	0.31
Short Term Debt	0.15	0.08	0.2	-0.03	0.03	0.22	0.17		0.24	-0.12	0.06	0.04	0.15	-0.13	-0.19	0.48	0.11	0.28	-0.36	0.38	-0.05	0.21	0.36	0.42	-0.5
Intangible Assets	0.91	0.87	0.93	0.79	0.74	0.94	0.78	0.24		0.62	0.93	0.87	0.41	-0.92	0.61	0.66	-0.52	-0.79	-0.15	0.76	-0.48	-0.31	-0.25	-0.18	0.28
Accounts Payable	0.87	0.91	0.78	0.57	0.81	0.8	0.7	-0.12	0.62		0.8	0.92	0.1	-0.85	0.98	0.04	-0.83	-0.85	0.53	0.07	-0.85	-0.9	-0.83	-0.83	0.7
Long Term Debt	0.98	0.95	0.99	0.86	0.89	0.99	0.89	0.06	0.93	0.8		0.94	0.46	-0.93	0.81	0.53	-0.6	-0.87	0.07	0.62	-0.54	-0.48	-0.44	-0.42	0.46
Good Will	0.98	0.99	0.92	0.71	0.86	0.95	0.81	0.04	0.87	0.92	0.94		0.24	-0.98	0.9	0.3	-0.8	-0.92	0.23	0.38	-0.79	-0.72	-0.64	-0.6	0.59
Short Term Investments	0.37	0.3	0.47	0.59	0.48	0.45	0.72	0.15	0.41	0.1	0.46	0.24		-0.26	0.11	0.52	0.05	-0.12	-0.26	0.57	0.18	0.22	0.23	0.19	-0.18
Common Stock	-0.97	-0.97	-0.91	-0.69	-0.8	-0.94	-0.79	-0.13	-0.92	-0.85	-0.93	-0.98	-0.26		-0.82	-0.37	0.8	0.9	-0.11	-0.46	0.76	0.64	0.52	0.48	-0.51
Property Plant Equipment	0.86	0.89	0.78	0.61	0.81	0.79	0.7	-0.19	0.61	0.98	0.81	0.9	0.11	-0.82		0.06	-0.78	-0.86	0.52	0.09	-0.77	-0.86	-0.8	-0.83	0.71
Current Deferred Revenue	0.43	0.32	0.6	0.62	0.3	0.55	0.44	0.48	0.66	0.04	0.53	0.3	0.52	-0.37	0.06		0.19	-0.18	-0.45	0.95	0.2	0.36	0.38	0.35	-0.38
Long Term Investments	-0.71	-0.78	-0.55	-0.29	-0.58	-0.61	-0.5	0.11	-0.52	-0.83	-0.6	-0.8	0.05	0.8	-0.78	0.19		0.78	-0.36	0.1	0.9	0.86	0.67	0.65	-0.72
Short Long Term Debt	-0.87	-0.89	-0.8	-0.7	-0.74	-0.82	-0.65	0.28	-0.79	-0.85	-0.87	-0.92	-0.12	0.9	-0.86	-0.18	0.78		-0.24	-0.32	0.68	0.68	0.63	0.62	-0.69
Net Tangible Assets	0.14	0.21	0.06	-0.02	0.16	0.05	0.05	-0.36	-0.15	0.53	0.07	0.23	-0.26	-0.11	0.52	-0.45	-0.36	-0.24		-0.49	-0.47	-0.66	-0.72	-0.78	0.45
Deferred Long Term Liab	0.5	0.4	0.65	0.72	0.36	0.62	0.52	0.38	0.76	0.07	0.62	0.38	0.57	-0.46	0.09	0.95	0.1	-0.32	-0.49		0.17	0.33	0.34	0.35	-0.29
Long Term Debt Total	-0.69	-0.77	-0.53	-0.2	-0.56	-0.59	-0.46	-0.05	-0.48	-0.85	-0.54	-0.79	0.18	0.76	-0.77	0.2	0.9	0.68	-0.47	0.17		0.92	0.81	0.71	-0.63
Capital Surpluse	-0.61	-0.7	-0.45	-0.18	-0.55	-0.49	-0.4	0.21	-0.31	-0.9	-0.48	-0.72	0.22	0.64	-0.86	0.36	0.86	0.68	-0.66	0.33	0.92		0.92	0.89	-0.77
Net Invested Capital	-0.54	-0.62	-0.4	-0.2	-0.54	-0.42	-0.36	0.36	-0.25	-0.83	-0.44	-0.64	0.23	0.52	-0.8	0.38	0.67	0.63	-0.72	0.34	0.81	0.92		0.88	-0.78
Cash And Equivalents	-0.49	-0.57	-0.39	-0.21	-0.51	-0.38	-0.32	0.42	-0.18	-0.83	-0.42	-0.6	0.19	0.48	-0.83	0.35	0.65	0.62	-0.78	0.35	0.71	0.89	0.88		-0.76
Net Working Capital	0.49	0.56	0.37	0.13	0.5	0.4	0.31	-0.5	0.28	0.7	0.46	0.59	-0.18	-0.51	0.71	-0.38	-0.72	-0.69	0.45	-0.29	-0.63	-0.77	-0.78	-0.76

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Medtronic PLC

Working Capital Over Time

Based on the company's disclosures, Medtronic PLC has a Working Capital of 12.62 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The working capital for all United States stocks is significantly lower than that of the firm.

Medtronic Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic PLC's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics of similar companies.

Medtronic PLC is currently under evaluation in working capital category among related companies.

Medtronic PLC ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Medtronic Fundamentals

	Return On Equity	0.0817
	Return On Asset	0.0423
	Profit Margin	0.13 %
	Operating Margin	0.19 %
	Current Valuation	125 B
	Shares Outstanding	1.33 B
	Shares Owned By Insiders	0.10 %
	Shares Owned By Institutions	85.26 %
	Number Of Shares Shorted	12.43 M
	Price To Earning	20.44 X
	Price To Book	2.05 X
	Price To Sales	3.29 X
	Revenue	31.23 B
	Gross Profit	21.71 B
	EBITDA	9.04 B
	Net Income	3.78 B
	Cash And Equivalents	1.54 B
	Cash Per Share	8.59 X
	Total Debt	24.36 B
	Debt To Equity	0.51 %
	Current Ratio	1.76 X
	Book Value Per Share	38.95 X
	Cash Flow From Operations	6.04 B
	Short Ratio	1.96 X
	Earnings Per Share	3.15 X
	Price To Earnings To Growth	1.52 X
	Target Price	94.0
	Number Of Employees	95 K
	Beta	0.78
	Market Capitalization	107.94 B
	Total Asset	90.95 B
	Retained Earnings	30.39 B
	Working Capital	12.62 B
	Current Asset	23.6 B
	Current Liabilities	7.17 B
	Annual Yield	0.03 %
	Five Year Return	2.18 %
	Net Asset	90.95 B
	Last Dividend Paid	2.75

About Medtronic PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:

How To Invest In Medtronic

Details

Is Medtronic Stock a good investment?

Details

What is Medtronic PLC's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Medtronic PLC Piotroski F Score and Medtronic PLC Altman Z Score analysis.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Medtronic Stock analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.078

Dividend Share

2.75

Earnings Share

3.15

Revenue Per Share

24.298

Quarterly Revenue Growth

0.047

The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medtronic Plc Stock Working Capital

Medtronic PLC Company Working Capital Analysis

Working Capital

Current Assets

-

Current Liabilities

Current Medtronic PLC Working Capital

Medtronic Working Capital Driver Correlations

Medtronic Working Capital Peer Comparison

Medtronic PLC ESG Sustainability

Medtronic Fundamentals

About Medtronic PLC Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Medtronic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY